Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Voting Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021 [1]   6,641,914    
Beginning balance at Dec. 31, 2021 $ 101,683 $ 9 [1] $ 169,916 $ (68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares) [1]   9,298    
Stock-based compensation 11,042   11,042  
Net loss (25,772)     (25,772)
Ending balance (in shares) at Mar. 31, 2022 [1]   6,651,212    
Ending balance at Mar. 31, 2022 86,953 $ 9 [1] 180,958 (94,014)
Beginning balance (in shares) at Dec. 31, 2021 [1]   6,641,914    
Beginning balance at Dec. 31, 2021 101,683 $ 9 [1] 169,916 (68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for debt modification 116      
Net loss (57,435)      
Ending balance (in shares) at Jun. 30, 2022 [1]   7,243,728    
Ending balance at Jun. 30, 2022 135,437 $ 9 [1] 261,105 (125,677)
Beginning balance (in shares) at Mar. 31, 2022 [1]   6,651,212    
Beginning balance at Mar. 31, 2022 86,953 $ 9 [1] 180,958 (94,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for business combination (in shares) [1]   434,969    
Issuance of common stock for business combination 50,948   50,948  
Issuance of common stock for debt modification (in shares) [1]   148,687    
Issuance of common stock for debt modification 17,416   17,416  
Issuance of common stock upon exercise of warrants (in shares) [1]   1    
Vesting of restricted stock units, net (in shares) [1]   8,859    
Stock-based compensation 11,783   11,783  
Net loss (31,663)     (31,663)
Ending balance (in shares) at Jun. 30, 2022 [1]   7,243,728    
Ending balance at Jun. 30, 2022 $ 135,437 $ 9 [1] 261,105 (125,677)
Beginning balance (in shares) at Dec. 31, 2022 7,976,980 7,976,980 [1]    
Beginning balance at Dec. 31, 2022 $ 121,333 $ 10 [1] 300,636 (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares) [1]   41,502    
Stock-based compensation 6,361   6,361  
Net loss (23,527)     (23,527)
Ending balance (in shares) at Mar. 31, 2023 [1]   8,018,482    
Ending balance at Mar. 31, 2023 $ 104,167 $ 10 [1] 306,997 (202,840)
Beginning balance (in shares) at Dec. 31, 2022 7,976,980 7,976,980 [1]    
Beginning balance at Dec. 31, 2022 $ 121,333 $ 10 [1] 300,636 (179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for debt modification 0      
Net loss $ (34,203)      
Ending balance (in shares) at Jun. 30, 2023 8,188,981 8,188,981 [1]    
Ending balance at Jun. 30, 2023 $ 98,280 $ 1 [1] 311,795 (213,516)
Beginning balance (in shares) at Mar. 31, 2023 [1]   8,018,482    
Beginning balance at Mar. 31, 2023 104,167 $ 10 [1] 306,997 (202,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares) [1]   171,051    
Reclass of par value related to additional paid in capital 0 $ (9) 9  
Cash paid for fractional shares from the Reverse Stock Split (in shares) [1]   (552)    
Cash paid for fractional shares from the Reverse Stock Split (3)   (3)  
Stock-based compensation 4,792   4,792  
Net loss $ (10,676)     (10,676)
Ending balance (in shares) at Jun. 30, 2023 8,188,981 8,188,981 [1]    
Ending balance at Jun. 30, 2023 $ 98,280 $ 1 [1] $ 311,795 $ (213,516)
[1] Share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.